Dandan Li

5PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 16, 2026
Efficacy and Safety of Co-Ablation Combined With Aintilimab for Metastatic Melanoma to the Liver (CryoCheck-001): A Phase II Trial.

|Apr 27, 2026
Optimal Adjuvant Therapy Selection for Chinese BRAF V600-Mutant Stage III Melanoma: A Multicenter Efficacy Comparison of Targeted Agents, Immunotherapy, and Combinatorial Strategies.

|Feb 19, 2025
Addition of anti-PD-1 immunotherapy to BRAF inhibitor-based targeted therapy improves real-world survival and delays brain metastases in patients with BRAFV600-mutant advanced melanoma: a multicenter cohort study.

Junwan Wu, Qiuyue Ding, Qiong Zhang

|Feb 05, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial.

Run-Cong Nie, Shu-Qiang Yuan, Ya Ding

|Jun 10, 2023
A pilot study of lymphodepletion intensity for peripheral blood mononuclear cell-derived neoantigen-specific CD8 + T cell therapy in patients with advanced solid tumors.

Dandan Li, Chao Chen, Jingjing Li

Pageof 1

Frequent Collaborators

1 joint publications

Mu-Yan Cai

1 joint publications

Jianhui Yue

1 joint publications

Hailun Wang

1 joint publications

Le Zhang